Procarta Biosystems

Developer of oligonucleotide-based therapeutics against antimicrobial resistance

placeNorwich, England, United Kingdom calendar_todayFounded 2007 groups3 employees language procartabio.com

Registered entities

Investor mix

16 investors on record; lead investors include REPAIR Impact Fund, UK Innovation Science & Seed Fund, Morningside.

Investor typeCountShare
Venture capital638%
Private equity213%
Other / undisclosed850%
Coming soon